Behavioral Impediments to Beneficial Experimentation

Last registered on January 29, 2024
View Trial History

Pre-Trial

Trial Information

General Information

Title
Behavioral Impediments to Beneficial Experimentation
RCT ID
AEARCTR-0011442
Initial registration date
May 18, 2023

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
May 24, 2023, 4:58 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
January 29, 2024, 9:48 AM EST

Last updated is the most recent time when changes to the trial's registration were published.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Name
Elissa Gentry
Affiliation
FSU College of Law
Contact Primary Investigator

Other Primary Investigator(s)

PI Name
W. Kip Viscusi
PI Affiliation
Vanderbilt University
Contact Investigator

Additional Trial Information

Status
On going
Start date
2023-05-18
End date
2024-06-01
Keywords
Health
Additional Keywords
Risk, Informed Consent
JEL code(s)
I12, I18, D81, K13
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
This project explores consumers’ sensitivity to estimate precision and data quality in their willingness to experiment. Using an incentive-compatible experimental design, we measure participants’ willingness to pay for additional information about uncertain treatments and ability to update their prior beliefs based on this new information.
External Link(s)

Registration Citation

Citation
Gentry, Elissa and W. Kip Viscusi. 2024. "Behavioral Impediments to Beneficial Experimentation." AEA RCT Registry. January 29. https://doi.org/10.1257/rct.11442-4.0
Sponsors & Partners
Experimental Details

Interventions

Intervention(s)
We provide different risk data to understand participants' 1) willingness to purchase such data and 2) how they incorporate this data into their risk assessment of uncertain treatments.
Intervention Start Date
2023-05-18
Intervention End Date
2024-06-01

Primary Outcomes

Primary Outcomes (end points)
1) Determinants of the decision to purchase new information and 2) the incorporation of new information for risk perceptions.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
We provide different risk data to understand participants' 1) willingness to purchase such data and 2) how they incorporate this data into their risk assessment of uncertain treatments.
Experimental Design Details
Not available
Randomization Method
Survey is administered in Qualtrics, which provides randomization services.
Randomization Unit
Individuals are randomly assigned to 3 treatment groups. Within individuals, drug characteristics and sample proportion/price are also randomized.
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
0
Sample size: planned number of observations
300
Sample size (or number of clusters) by treatment arms
100 random, 100 voluntary, 100 voluntary plus educational treatment.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
Supporting Documents and Materials
IRB

Institutional Review Boards (IRBs)

IRB Name
Florida State University
IRB Approval Date
2023-05-16
IRB Approval Number
STUDY00003405
Analysis Plan